Boerman Manja
- SEC CIK
- 0001939253
No open-market purchases or sales filed in the past year.
Current role at each company
- CTLT Catalent, Inc.Pres. BioModalities Divisionas of May 3, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Boerman Manja as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 3, 2023 (view filing) | May 1 | 2 days | Boerman ManjaPres. BioModalities Division | SSale | −1.45K | $49.86 | −$72.1K | −9.1%14.4K after | |
| Dec 7, 2022 (view filing) | Dec 5 | 2 days | Boerman ManjaPres. BioModalities Division | SSale | −780 | $51.70 | −$40.3K | −4.7%15.9K after | |
| Aug 26, 2022 (view filing) | Aug 25 | 1 day | Boerman ManjaPres. BioModalities Division | SSale | −3.30K | $103.04 | −$339.6K | −16.5%16.6K after |